Sign in

CIK 0000886163 · Large accelerated filer

LIGAND PHARMACEUTICALS INC

Sign in to watch
Tickers
LGND LGNDZ LGNXZ LGNYZ LGNZZ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770160744
Phone
858-550-7500
Business address
3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
Former names
LIGAND PHARMACEUTICALS

Securities

  • LGND Common Stock Nasdaq
  • LGNDZ Common stock OTC
  • LGNXZ Common stock OTC
  • LGNYZ Common stock OTC
  • LGNZZ Common stock OTC
  1. 425 Deal Prospectus/Communication re Business Combination
  2. 425 Deal Prospectus/Communication re Business Combination
  3. UPLOAD Other SEC-generated Letter
  4. 425 Deal Prospectus/Communication re Business Combination
  5. 425 Deal Prospectus/Communication re Business Combination
  6. 425 Deal Prospectus/Communication re Business Combination
  7. 425 Deal Prospectus/Communication re Business Combination
  8. S-4 Deal Registration Statement - Business Combination
  9. 425 Deal Prospectus/Communication re Business Combination
  10. 8-K Event Other events
  11. 425 Deal Prospectus/Communication re Business Combination
  12. SC 13G/A Stake Amended Statement of Ownership
  13. 425 Deal Prospectus/Communication re Business Combination
  14. 8-K Event Material agreement
  15. 425 Deal Prospectus/Communication re Business Combination
  16. 425 Deal Prospectus/Communication re Business Combination
  17. 425 Deal Prospectus/Communication re Business Combination
  18. 425 Deal Prospectus/Communication re Business Combination
  19. 425 Deal Prospectus/Communication re Business Combination
  20. 8-K Event Regulation FD disclosure

Page 84 of 115 · 2,300 filings